BB&T cuts entire ER department

http://www.cnbc.com/2016/07/28/bbt-cuts-jobs-as-i…

Surprised that this wasn't here already. But for any aspiring equity researchers (looking at those ppl who've messaged me as of late asking for advice), this is the risk of entering a field in decline. I remember BB&T was hiring not all that long ago (~1 yr ago) and whichever unlucky person got it ended up getting the really short end of the stick.

Now this isn't to say that sell-side ER is vanishing altogether. People who say that largely don't know what they're talking about. Having said that, the pain is real and breaking into the industry through a smaller regional shop potentially exposes an individual to unpredictable, binary eventualities such as this one.

In happier news... at least it's Friday. Cheers!

10 Comments
 

While there are cyclical trends in ER, there are ongoing, permanent reductions in industry wide headcount. Plenty of high ranked shops are also laying people off and having the survivors either pick up more coverage, or just dropping less profitable names altogether (either from an IBD or trading perspective), Obviously, the situation at BB&T is not a 'cyclical' development and as other smaller shops follow suit (e.g. Sterne Agee), there'll be an oversupply of ER professionals with nowhere to go.

However, as with all things, eventually we'll reach some equilibrium and hopefully the environment is a lot less depressing then. When this will come about and where the industry will ultimately end up though, I have no idea.

 
Best Response
Now this isn't to say that sell-side ER is vanishing altogether. People who say that largely don't know what they're talking about.

It may not be "vanishing altogether," but it is in serious decline and will continue to decline for many years. There are way too many brokers out there and headcount must go down significantly.

as with all things, eventually we'll reach some equilibrium and hopefully the environment is a lot less depressing then. When this will come about and where the industry will ultimately end up though, I have no idea.

100% agree. Unfortunately I don't see an end in sight. Maybe in 5-10 years after 50-70% of headcount leaves the industry. What people need to grasp is that the equity research revenue just isn't coming back. Soft dollars are going way down.

Where do you think these oversupply ER professionals will likely end up?

I've seen some enter the industry they previously covered. A classic exit route is going into investor relations. The problem is the compensation differential is huge.

 

Varies shop by shop. I've heard of relatively recent layoffs at a number of them, including the top ranked firms. And unlike before, not as many boutiques for these guys to fall back on.

 

Fugiat velit amet officia non quibusdam facere. Aspernatur voluptas esse sed optio quis vel. Quaerat cum pariatur eaque veniam porro illo libero atque.

Eligendi fuga repellat voluptatem. Ex inventore ut rerum velit facilis. Dolores voluptas fugit aperiam et.

Rerum qui repudiandae earum hic. Voluptatem molestiae sunt odio ut. Error necessitatibus accusamus numquam et numquam. Ea est corrupti quis temporibus illo et omnis quos. Omnis minima et inventore reiciendis nostrum ut quis ipsam. Atque tempora sit est eligendi possimus. Voluptatum deserunt eos voluptatum iusto est accusantium blanditiis saepe.

Magnam sequi necessitatibus consequatur. Et eos ipsam cum perferendis sequi repellat omnis corrupti. Ab incidunt qui quo quaerat rerum fuga cum dolorem.

Career Advancement Opportunities

August 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.4%
  • Morgan Stanley 08 97.8%
  • Goldman Sachs 02 97.3%

Overall Employee Satisfaction

August 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Evercore No 98.9%
  • Morgan Stanley 01 98.4%
  • Banco Santander 02 97.8%
  • BMO Capital Markets 12 97.3%

Professional Growth Opportunities

August 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.4%
  • Goldman Sachs 01 97.8%
  • JPMorgan No 97.3%

Total Avg Compensation

August 2026 Investment Banking

  • Vice President (16) $429
  • Associates (50) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (25) $178
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (75) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
kanon's picture
kanon
99.0
5
DrApeman's picture
DrApeman
98.9
6
CompBanker's picture
CompBanker
98.9
7
Betsy Massar's picture
Betsy Massar
98.9
8
dosk17's picture
dosk17
98.9
9
GameTheory's picture
GameTheory
98.9
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”